A new report on the Global Retinal Detachment Market, published by Market Research Future (MRFR), envisions that this market could recognize hike at 5.9% CAGR between 2016 and 2023. In terms of money value, the market can be worth USD 2689.2 Mn by the end of the forecast period.
Market Synopsis
Retinal detachment is the separation of retina from its supporting layers. Most of the retinal detachments occur due to retinal break, hole, or tear. The biggest market driving factor for the global retinal detachment market growth are increasing prevalence of retinal detachment and changing technology. Hospitals are adopting new medical devices for early as well as effective diagnosis and treatment management.
Other market driving factors include rapidly changing healthcare sector, increasing healthcare expenditure, presence of advanced medical sector in developed countries, availability of many advanced medical treatments, subsequent increase in demand for advanced medical treatment, increasing awareness of this disorder, increasing efforts by market players for research & development (R&D), government initiatives to improve public health, and extended insurance cover.
Avail FREE Sample at: https://www.marketresearchfuture.com/sample_request/1640
Key Players
Big players in the global retinal detachment market include –
Carl Zeiss Meditec Inc. (USA)
Centervue SpA (Italy)
Co:Lab Pensacola (USA)
Eyenuk Inc (USA)
HealPros LLC (USA)
Imagine Eyes (France)
NeuroVision Imaging LLC (USA)
Optos (UK)
Peek Vision Ltd. (UK)
Market Segmentation
The global retinal detachment market segmentation encompasses diagnosis, end-user, treatment, and type. MRFR’s take on the market explores various facets of the market in-depth.
The diagnosis-based segmentation of this market covers fluorescein angiography, fundus photos, imaging tests, retinal examination, visual field test, and others. The imaging tests segment can be sub-segmented into have been ultrasound imaging and others. Ultrasound imaging has been further segmented into A-Scan, B-scan, and others.
Based on end-user, the market has been segmented into academic institutes, eye hospital & clinics, medical research centers, and others. By type, the market has been segmented into exudativem, hegmatogenous, tractional, and others.
Regarding treatment, the market has been segmented into retinal detachment, retinal tears, and others. Retinal detachment is further sub-segmented into pneumatic retinopexy, scleral, vitrectomy, and others. Retinal tears segment has been sub-segmented into freezing (cryopexy), laser surgery (photocoagulation), and others.
Browse Complete Details of This Report at: https://www.marketresearchfuture.com/reports/retinal-detachment-treatment-market-1640
Regional Segmentation
A geographical outlining of the global retinal detachment market covers the Americas (North America & Latin America), Asia Pacific, Europe, and the Middle East & Africa (MEA).
The Americas is the largest regional market with North America alone displaying the potential to be the largest regional market. Technological advancement and the availability of advanced medical facilities, funding for R&D, presence of major market players, high disposable income, and more investment in healthcare, make North America the bigger regional market segment compared to Latin America. Maximum market players, as well as revenue in this region, can be seen in the USA, followed by Canada.
Europe is the second-largest regional market. Government investment and support for the healthcare industry, high density of population, high disposable income, and presence of some key market players are triggering this growth. The most powerful country-specific markets in Western Europe are France, Germany, Italy, Spain, and the UK. An observation of the remaining countries in Western Europe featured in this report speculate the huge addition to market revenue from some other countries in this region, along with a sizable amount of revenue from Eastern Europe.
Due to developing healthcare infrastructure, increasing awareness, surging healthcare expenditure, and growing adoption of new devices as well as treatment options, Asia Pacific region can be the fastest growing regional market during the forecast period. Vital country-specific markets in this region are India, China, Japan, and South Korea. An analysis of the remaining countries in the Asia Pacific region featured in this report estimates the huge contribution to market revenue from some other countries.
The MEA region is expected to grow slower during the forecast period. UAE and Saudi Arabia are dominating this market due to high income, availability of top-class medical facilities, and government support to improve public healthcare. Egypt is another important country-specific market in this region. A valuation of the remaining countries in the MEA region featured in this report anticipates a decent contribution to market revenue from some other countries.
Get an Exclusive Discount on this Report at: https://www.marketresearchfuture.com/check-discount/1640
Latest Industry News
Biopharmaceutical company ONL Therapeutics Inc. has raised USD 3 Mn in a convertible note financing. This company is developing novel therapies for protecting the vision of patients with retinal ailments. 22 AUG 2019
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment